Niloofar Karaji
About Niloofar Karaji
Niloofar Karaji is a Senior Scientist in Process Development at Adaptimmune, where she has worked since 2021. She has an extensive academic and professional background, including roles at the University of Oxford and Orbit Discovery, and holds a PhD in Cell and Molecular Biology.
Work at Adaptimmune
Niloofar Karaji has been serving as a Senior Scientist in Process Development at Adaptimmune since 2021. In this role, she focuses on advancing the development of innovative therapies in the field of immunotherapy. Her work contributes to the company's mission of harnessing the power of T-cell therapy to treat cancer. Based in the United Kingdom, she has been part of the team for three years, applying her extensive background in molecular biology and biotechnology to enhance the company's research and development efforts.
Education and Expertise
Niloofar Karaji holds a Doctor of Philosophy (PhD) in Cell and Molecular Biology in Health and Disease from the University of Oxford, which she completed from 2014 to 2019. She also earned a Master of Science (MS) in Molecular Biotechnology from the University of Bonn, studying there from 2011 to 2014. Her academic journey began with a Bachelor of Science (BS) in Cell/Cellular and Molecular Biology from Shahid Beheshty University in Tehran, Iran, from 2006 to 2010. This strong educational foundation supports her expertise in process development and T-cell research.
Background
Niloofar Karaji has a diverse professional background in scientific research and development. She began her career as a Student Assistant at the University of Bonn, where she worked in two separate roles from 2011 to 2013. Following this, she served as a Research Assistant at the Center of Advanced European Studies and Research in Bonn, Germany, from 2013 to 2014. Niloofar then pursued her PhD at the University of Oxford, where she later became a Postdoctoral Research Fellow for six months in 2018-2019. After her postdoctoral work, she joined Orbit Discovery, where she held various roles related to T-cell receptor discovery until 2021.
Professional Experience
Niloofar Karaji has accumulated significant experience in the field of molecular biology and immunotherapy. After completing her PhD, she worked as a Postdoctoral Research Fellow at the University of Oxford for six months. She then transitioned to Orbit Discovery, where she served as Lead Scientist and later as Team Lead/Senior Scientist in TCR discovery from 2019 to 2021. Her roles involved leading research initiatives and contributing to advancements in T-cell receptor technology, which are critical for developing targeted cancer therapies.